Keyword: Active Pharmaceutical Ingredients (APIs)
News
14.06.2016
- Carbogen Amcis, a Swiss company specialized in process development and manufacturing of Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, is expanding its...
News
20.04.2016
- Sweden’s Recipharm has boosted its position in global contract development and manufacturing operations (CDMO) with agreements to buy Kemwell’s businesses in Sweden, the US and...
News
20.04.2016
- Johnson Matthey, a US provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced plans to collaborate with Cambridge, UK...
News
08.04.2016
- Aesica Pharmaceuticals has doubled development capacity at its site in Queenborough, Kent, UK, giving it the capability to manufacture multiple drug products up to Phase III...
Plant Construction & Process Technology
05.04.2016
- Pharmaceutical companies of all sizes now routinely outsource many of their research, development and/or manufacturing requirements to contract organizations around the world...
Strategy & Management
04.04.2016
- In September of 2015, Siegfried completed all closing conditions for its acquisition of the custom synthesis business of BASF and parts of the German group’s active pharmaceutical...
News
24.03.2016
- French private equity fund Ardian has started talks with two buy-out firms for the sale of its majority stake in chemicals and pharmaceuticals producer Novacap. The firm is in...
News
15.03.2016
- Swiss fine chemical company Dottikon is investing more than 100 million Swiss francs ($101 million) at its site in Aargau to add chemical process development and production...
